Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Telix Pharmaceuticals Limited - American Depositary Shares (NQ: TLX )

19.50 +2.09 (+12.00%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,684
Open 19.13
Bid (Size) 18.00 (5)
Ask (Size) 20.00 (1)
Prev. Close 17.41
Today's Range 19.01 - 20.00
52wk Range 14.01 - 20.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
From Telix Pharmaceuticals Limited
Via GlobeNewswire

Performance

YTD
+30.00%
+30.00%
1 Month
+14.44%
+14.44%
3 Month
+32.65%
+32.65%
6 Month
+28.71%
+28.71%
1 Year
+28.71%
+28.71%

More News

Read More
Illuccix® Approved in the United Kingdom
From Telix Pharmaceuticals Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Completes Acquisition of RLS (USA) Inc.
From Telix Pharmaceuticals Limited
Via GlobeNewswire
SLB Posts Upbeat Results, Joins Bank OZK, Qorvo And Other Big Stocks Moving Higher On Friday
Via Benzinga
Illuccix® Receives European Approval
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
From Telix Pharmaceuticals Limited
Via GlobeNewswire
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
From Telix Pharmaceuticals Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.